SIDNEY BERRYMAN: Open Payments
NPI 1730892530 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,473 in 95 payments from 19 companies in 2025. Trend: 2023 $1,083 · 2024 $1,721 · 2025 $1,473
Food & beverage: $1,473
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $325 |
| ABBVIE INC. | 29 | $222 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $163 |
| Phathom Pharmaceuticals, Inc. | 2 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $141 |
| Axsome Therapeutics, Inc. | 6 | $108 |
| PFIZER INC. | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Novo Nordisk Inc | 3 | $44 |
| Lilly USA, LLC | 2 | $39 |
Products named: VOQUEZNA, BREZTRI, CAPLYTA, AIRSUPRA, RELISTOR, QULIPTA, UBRELVY, Auvelity.
Industry payments across AL — which companies pay providers there.
